ENvue Medical, Inc.
FEED
$0.82
-$0.01-1.47%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -104.17% | -798.11% | 151.10% | -386.63% | -218.37% |
| Total Depreciation and Amortization | 1,105.56% | -- | -- | 36,300.00% | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 204.44% | 4,740.84% | -3,146.74% | -2,421.21% | -131.91% |
| Change in Net Operating Assets | -235.61% | -2.89% | -5.71% | 263.37% | 521.21% |
| Cash from Operations | -221.07% | -388.32% | -135.65% | -511.75% | -131.95% |
| Capital Expenditure | -240.00% | -- | -- | -100.00% | -400.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -111.89% | -- | -- | -100.00% | 14,400.00% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | 4,907.14% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 122.86% | -- | 18,322.22% | 24,364.29% | -- |
| Foreign Exchange rate Adjustments | -- | 240.00% | 0.00% | -33.33% | 66.67% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1,217.22% | -392.95% | 437.57% | 752.64% | 74.10% |